Kit media
Cetiat is innovating in the field of liquid flow, with the design of a device unique in the world to measure the activity of radio-pharmaceutical drugs, with the aim of reducing the risks of over and unders and balances for patient safety.
The Cetiat liquid micro-flow laboratory, a pioneer in Europe, allows the characterization of medical devices in order to reduce the risk of over and under-dosing, for example for diabetics, for premature babies or in the case of painkiller injection.
In this context, from 2012 to 2015, Cetiat, in a consortium of European laboratories, participated in the Research Project Metrology for Drug Delivery, funded by the European Commission and aimed at improving the traceability of medical infusion devices. Building on this research, the technical centre is working on the design of a measuring device for nuclear medicine in the context of examinations requiring the use of radioactive products.
Find out more: www.cetiat.fr
